Biotin fails to help MS in latest trial Published: 02 November 2020 A recent phase III trial has found that high-dose pharmaceutical-grade biotin (MD1003) does not improve disability or walking speed in people with progressive multiple sclerosis (MS).  This outcome disappointed researchers because an earlier trial had found that biotin,